These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36134049)

  • 1. An Uncommon Correlation of Rheumatoid Arthritis and Lupus Nephritis: A Case Report on the Unusual Progression of Lupus Nephritis.
    Lam LC; Yadav VD; Mihal VJ
    Cureus; 2022 Aug; 14(8):e27620. PubMed ID: 36134049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dilemma: scleroderma renal crisis vs lupus nephritis in a patient with mixed connective tissue disorder.
    Jackson N; Betty S; Appiah-Pippim J; Bueno Y; Makhdumi S
    J Community Hosp Intern Med Perspect; 2021; 11(6):852-855. PubMed ID: 34804405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.
    Erdener D; Aksu K; Biçer I; Doğanavşargil E; Kutay FZ
    J Clin Lab Anal; 2005; 19(4):172-6. PubMed ID: 16025478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature.
    Simmons SC; Smith ML; Chang-Miller A; Keddis MT
    Am J Nephrol; 2015; 42(6):451-9. PubMed ID: 26812129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the treatment of systemic lupus erythematosus with belimumab in children.
    Deng WP
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1069-1074. PubMed ID: 34719425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel case of lupus nephritis and mixed connective tissue disorder in a COVID-19 patient.
    Ali S; Almas T; Zaidi U; Ahmed F; Shaikh S; Shaikh F; Tafveez R; Arsalan M; Antony I; Antony M; Tahir B; Aborode AT; Ali M; Nagarajan VR; Samy A; Alrawashdeh MM; Alkhattab M; Ramjohn J; Ramjohn J; Huang H; Nawaz QS; Khan KA; Khullar S
    Ann Med Surg (Lond); 2022 Jun; 78():103653. PubMed ID: 35495962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
    Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
    Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
    Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of lupus nephritis in Saudi lupus patients: A retrospective observational study.
    Albirdisi MR; Al-Homood IA
    Lupus; 2020 Oct; 29(12):1638-1643. PubMed ID: 32741304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay.
    Petrackova A; Smrzova A; Gajdos P; Schubertova M; Schneiderova P; Kromer P; Snasel V; Skacelova M; Mrazek F; Zadrazil J; Horak P; Kriegova E
    Clin Proteomics; 2017; 14():32. PubMed ID: 29026368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis.
    Frieri M; Heuser W; Bliss J
    J Pharmacol Pharmacother; 2015; 6(2):71-6. PubMed ID: 25969652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
    Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
    Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
    Mahajan A; Amelio J; Gairy K; Kaur G; Levy RA; Roth D; Bass D
    Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus.
    Leitao AR; Jain MS; Luvsannyam E; Jayswal V; Tiesenga F
    Cureus; 2022 May; 14(5):e24973. PubMed ID: 35698669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
    Kim KJ; Kim JY; Baek IW; Kim WU; Cho CS
    J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.